Since VEGF production is elevated in many tumors including ovarian cancer, therapeutic strategies targeting VEGF and VEGF receptor signaling can inhibit angiogenesis and have been tested in clinical trials [26]. Here, VEGFA is linked to ovarian carcinoma.